All Type of News
International trade in deficit despite export increase.
The pharmaceutical export in 2002 increased by 10.5% from the previous year while the import more by 53.8% up, showing a deficit balance in the international trade.
The total export in 2002 was amounted to U...
Domestic simvastatin market getting heated
With the incessant launchings of patent-expired simvastatin preparations, lipid-lowering agent, fierce competitions between domestic and foreign-invested pharmaceutical firms are being flared up.
Informed sources ...
Bioequivalence testing emerging as critical issue in domestic pharmaceutical industry
Pharmaceutical business sources say that pharmaceutical manufacturing firms should pay more attention to bioequivalence testing due to that a variety of government policies designed to stabilize the finance of Nationa...
Establishment of new natural product R&D center eyed
The KFDA and herbal drug manufacturers agreed to establish a new natural product based R&D center during this March in a bid to support the development of new oriental medicines and natural products and explore overse...
Franchise business community to reinforce "Brand Value"
"Brand Value" is a short-cut way for the management expansion.
The strengthening policy on "Brand Value" for consumers has been a compelling mandate to the pharmacy franchise business community.
Most of pharmacy...
License and distribution system of OTCs to be drastically ameliorated
During a brief session with the Korea Food and Drug Administration (KFDA) on February 6, ten leading OTC markers including Dongwha Pharma and Yuhan Corp. urged the government to ameliorate the OTC-related regulations ...
Procedures for manufacturing and product license to be separated
The KFDA said it would streamline some administrative regulations together with its support plan, in order to ensure the earlier commercialization of biodrugs via scientific and efficient evaluation on the recent outc...
Patients complained with duplicate tests and expensive wards.
The Korea Consumer Protection Board (KCPB) surveyed 588 consumers using the third medical institutions in big cities and reported that the most common complains included duplicate tests, unwanted expensive ward alloca...
Anticancer candidate substance RX-0201 likely to be commercialized in 2007
Korean health food maker Rexgene Biotech and Maryland-based Rexahn Corporation in the US, said it made a joint research agreement on RX-0201, a promising anticancer substances, on February 6.
Under the agreement, ...
Il Yang to sell a non-medicated anti-hypertension device.Il Yang made a contract with InterCure Co. for the distribution of RESPeRate, a medical device for the anti-hypertension, first in Asia.
RESPeRATE was approved by the U. S. F...
|
